Adverse Outcomes Associated With Corticosteroid Use in Critical COVID-19: A Retrospective Multicenter Cohort Study

Adverse Outcomes Associated With Corticosteroid Use in Critical COVID-19: A Retrospective Multicenter Cohort Study

Corticosteroid is commonly used to reduce damage from inflammatory reactions in coronavirus disease 2019 (COVID-19). We aim to determine the outcomes of corticosteroid use in critically ill COVID-19 patients. Ninety six critically ill patients, hospitalized in 14 hospitals outside Wuhan from January...

Full description

Bibliographic Details
Main Authors: Yichen Li, Jie Li, Jia Ke, Na Jiao, Lixin Zhu, Lihan Shen, Lei Chen, Zhiqiang Jiang, Sijing Cheng, Yibo Huang, Yifeng Zou, Ruixin Zhu, Guangjun Yan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Medicine
Subjects:
SARS-CoV-2
mortality
critical
gluocorticoid
steroid
COVID-19
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.604263/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.604263/full

Similar Items